Insider Transactions in Q1 2022 at Editas Medicine, Inc. (EDIT)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 03
2022
|
Michelle Robertson EVP, CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
767
-0.9%
|
$13,039
$17.33 P/Share
|
|
Mar 03
2022
|
Bruce Eaton EVP, CBO AND CTO |
SELL
Open market or private sale
|
Direct |
403
-0.59%
|
$6,851
$17.33 P/Share
|
|
Feb 10
2022
|
Michelle Robertson EVP, CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
53,499
+38.64%
|
-
|
|
Feb 10
2022
|
Mark S Shearman EVP, CHIEF SCIENTIFIC OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
31,709
+30.14%
|
-
|
|
Feb 10
2022
|
Bruce Eaton EVP, CBO AND CTO |
BUY
Grant, award, or other acquisition
|
Direct |
37,593
+35.34%
|
-
|
|
Feb 08
2022
|
Bruce Eaton EVP, CBO AND CTO |
SELL
Open market or private sale
|
Direct |
302
-0.96%
|
$5,134
$17.63 P/Share
|
|
Jan 11
2022
|
Michelle Robertson EVP, CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
1,744
-5.25%
|
$43,600
$25.7 P/Share
|
|
Jan 03
2022
|
James C Mullen CEO |
SELL
Open market or private sale
|
Direct |
18,252
-19.39%
|
$474,552
$26.95 P/Share
|